Equivalent Glycemic Load and Insulinemic Response Elicited by 7 Low Carbohydrate Products in Healthy Adults
1 other identifier
interventional
25
1 country
1
Brief Summary
The purpose of this study is to test the hypothesis that the equivalent glycemic load (EGL) value of portions of white bread containing 5 g available carbohydrate measured in this study is accurate and precise to within 1 gram. Additionally, the EGL of 7 low carbohydrate foods will be measured to determine their glycemic impact.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 4, 2023
CompletedFirst Posted
Study publicly available on registry
May 23, 2023
CompletedStudy Start
First participant enrolled
June 15, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 3, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 27, 2023
CompletedApril 22, 2025
April 1, 2025
4 months
May 4, 2023
April 17, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Equivalent glycemic load
Equivalent glycemic load (EGL) for each test food, expressed as \[EGL = T/(W/Cwb)\] where T is the plasma glucose incremental area under the curve over 120 minutes (iAUC) elicited by one serving of test food, W is the mean iAUC elicited by the mean of two WB20 tests and Cwb is the amount of available carbohydrate in the WB20.
-5 minutes to 120 minutes
Secondary Outcomes (2)
Insulin iAUC over 120 minutes
-5 minutes to 120 minutes
Glucose iAUC over 120 minutes
-5 minutes to 120 minutes
Study Arms (9)
Peanut Butter Cereal
EXPERIMENTALConsumption of Peanut Butter Cereal
Cinnamon Almond Cereal
EXPERIMENTALConsumption of Cinnamon Almond Cereal
Sriracha Crisps
EXPERIMENTALConsumption of Sriracha Crisps
Cheddar Crisps
EXPERIMENTALConsumption of Cheddar Crisps
Almond Blueberry Butter Bar
EXPERIMENTALConsumption of Almond Blueberry Butter Bar
Peanut Butter and Dark Chocolate Bar
EXPERIMENTALConsumption of Peanut Butter and Dark Chocolate Bar
Almond Dark Chocolate Bar
EXPERIMENTALConsumption of Almond Dark Chocolate Bar
White Bread 5 g available carbohydrate
EXPERIMENTALConsumption of white bread containing 5 g available carbohydrate
White Bread 20 g available carbohydrate
ACTIVE COMPARATORConsumption of white bread containing 20 g available carbohydrate
Interventions
Food
Eligibility Criteria
You may qualify if:
- Adults aged 18-75 inclusive
- Willing to abstain from unusual strenuous exercise and consuming alcoholic drinks for 24 hours before study days
- Willing to refrain from smoking tobacco or marijuana for 12h before and during study visits
- Understanding the study procedures and willing to provide informed consent to participate in the study and authorization to release relevant protected health information to the study investigator
- Subjects must be eligible to receive income in Canada and be covered by a health insurance plan such as OHIP
You may not qualify if:
- Pregnant or lactating individuals
- Personal history of diabetes
- Major trauma or surgical event within 3 months of screening
- The presence of any laboratory result, health condition, illness or drug use that increases risk to the subject or to others or may affect the results, as judged by the Qualified Investigator
- Unwillingness or inability to comply with experimental procedures and to follow INQUIS safety guidelines
- Known intolerance, sensitivity, or allergy to any ingredients in the study test meals. All allergens should be assumed to be a result of manufacturing practices.
- Subject is currently participating or recently (within 30 days of screening) participated in a clinical trial involving long-term exposure (greater than 24 hours) to an investigational drug, nutritional supplement or lifestyle modification
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- General Millslead
- INQUIS Clinical Researchcollaborator
Study Sites (1)
INQUIS Clinical Research, Ltd.
Toronto, Ontario, M5C 2N8, Canada
Related Publications (1)
Wolever TM, Miller K, Banh T. Equivalent Glycemic Load and Insulinemic Responses Elicited by Low-Carbohydrate Foods: A Randomized Trial in Healthy Adults. Curr Dev Nutr. 2025 Oct 30;9(12):107594. doi: 10.1016/j.cdnut.2025.107594. eCollection 2025 Dec.
PMID: 41439105DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 4, 2023
First Posted
May 23, 2023
Study Start
June 15, 2023
Primary Completion
October 3, 2023
Study Completion
October 27, 2023
Last Updated
April 22, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- De-identified participant data pertaining to glucose and insulin measurements will be available after publication and will be available until 3 years after the publication date.
- Access Criteria
- Please contact the study sponsor to request access to the data.
De-identified participant data pertaining to glucose and insulin measurements will be shared upon reasonable request.